Thursday, June 13, 2013

DNA from natural human genome cannot be patented, but a transformative process can (SCOTUS)


The Supreme Court has unanimously  that a human gene, or any natural DNA sequence from the human genome, cannot be patented.  A process to convert an RNA transcript to a complementary DNA can be patented, given Myraid Genetics a practical “monopoly”.  There are critics on Twitter today of that “exception”.
  
ARS Technica has the story by John Turner, here
 
The case would affect the ability of people born with cancer susceptibility genes (especially breast cancer, and this include men) to be screened (to be able to afford it) -- the "Angelina Jolie" situation.  

The case is Association of Molecular Patholgy v. Human Genetics, and the Supreme Court slip opinion is here.

No comments: